Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Arthrex Norway AS
AS
Active
Org 915459528
O.H. Bangs Vei 70, 1363
Høvik
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 11 years old
26 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Arthrex Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
152M
114M
76M
38M
0M
2021: 82M
82M
2021
2022: 81M (-1% vs 2021)
81M
-1%
2022
2023: 95M (+17% vs 2022)
95M
+17%
2023
2024: 107M (+13% vs 2023)
107M
+13%
2024
2025: 122M (+14% vs 2024)
122M
+14%
2025
EBITDA
NOK millions
16M
12M
8M
4M
0M
2021: 13M
13M
2021
2022: 10M (-23% vs 2021)
10M
-23%
2022
2023: 8M (-20% vs 2022)
8M
-20%
2023
2024: 3M (-62% vs 2023)
3M
-62%
2024
2025: 10M (+233% vs 2024)
10M
+233%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
121 700
106 504
95 317
81 044
81 564
Staff expenses
−28 401
−25 816
−21 344
−17 682
−15 465
EBITDA
9 520
3 429
8 116
9 975
13 465
Depreciation & amort.
−5 119
−4 112
−3 264
−3 707
−4 123
EBIT
4 401
−683
4 853
6 267
9 343
Net financials
−498
−53
−1 825
−287
1 409
Profit before tax
3 903
−736
3 028
5 980
10 752
Tax
1 054
141
386
1 268
2 370
Net profit
2 848
−877
2 642
4 712
8 382
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
41 866
41 645
40 747
33 446
31 391
Equity
24 021
21 172
22 050
19 408
16 856
Long-term debt
0
0
0
0
0
Short-term debt
17 845
20 473
18 697
14 038
14 535
Total debt
17 845
20 473
18 697
14 038
14 535
Financial ratios
5-year trend
EBITDA margin
7,8 %
This company
15,8 %
Market median
This company
Market median
51% below market
2021
2025
Equity ratio
57,4 %
This company
38,2 %
Market median
This company
Market median
50% above market
2021
2025
Return on equity
11,9 %
This company
18,4 %
Market median
This company
Market median
35% below market
2021
2025
Net profit margin
2,3 %
This company
8,1 %
Market median
This company
Market median
72% below market
2021
2025
Asset turnover
2,91×
This company
1,12×
Market median
This company
Market median
160% above market
2021
2025
Debt / equity
0,74×
This company
0,62×
Market median
This company
Market median
19% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-07-01 – 2021-06-30
View
PDF
More on Arthrex Norway AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
